DrugDashboards

Sodium Sulfacetamide 10 Sulfur 5 Cleanser

Sulfacetamide Sodium and Sulfur · SULFACETAMIDE SODIUM 10 mg/g; SULFUR 5 mg/g · Rinse · Topical · Acella Pharmaceuticals, LLC

NDC 42192-0136-08 · 227 g in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has jumped 108% in a year, to $0.3767 per gram — sharp rises like this often mean supply is already tightening. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Aug 2020Sep 2026$0.3767
56 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$339.07
Reported to Texas DSHS · 2026 annual filing · Acella Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$102,133
1,467 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for sulfacetamide sodium, sulfur (other) in the next 90 days

price up 35% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedApr 24, 2024
    Acella Pharmaceuticals, LLCSubpotent drug

Manufacturers of Sulfacetamide Sodium and Sulfur (Rinse)

LabelerStrengthFirst seenLast seen
Acella Pharmaceuticals, LLCSULFACETAMIDE SODIUM 10 mg/g; SULFUR 5 mg/gJul 15, 2026Sep 2, 2026
Acella Pharmaceuticals, LLCSULFACETAMIDE SODIUM 9 mg/g; SULFUR 4.5 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Sulfacetamide 10 Sulfur 5 Cleanser — NDC 42192-0136-08," retrieved September 3, 2026, https://drugdashboards.com/drug/42192013608.

Free to cite with attribution — see how the data is put together.